Perspective Therapeutics(CATX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CATX Perspective Therapeutics

休市中 10-16 16:00:00 EDT

2.17

-0.17

-7.26%

盘后2.22

+0.05+2.30%

19:57 EDT

最高2.34	最低2.15	成交量166.97万
今开2.34	昨收2.34	日振幅8.12%
总市值2.47亿	流通市值1.54亿	总股本1.14亿
成交额372.40万	换手率2.36%	流通股本7,082万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CATX","market":"US","secType":"STK","nameCN":"Perspective Therapeutics","latestPrice":2.17,"timestamp":1792180800000,"preClose":2.34,"halted":0,"volume":1669659,"hourTrading":{"tag":"盘后","latestPrice":2.22,"preClose":2.17,"latestTime":"19:57 EDT","volume":21020,"amount":46611.651,"timestamp":1792195076420,"change":0.05,"changeRate":0.023041,"amplitude":0.036866},"delay":0,"changeRate":-0.07264957264957263,"floatShares":70817000,"shares":113999999,"eps":-1.33,"marketStatus":"休市中","change":-0.17,"latestTime":"10-16 16:00:00 EDT","open":2.34,"high":2.34,"low":2.15,"amount":3724016.2827927005,"amplitude":0.081197,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.33,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"listingDate":1176955200000,"exchange":"AMEX","adjPreClose":2.34,"preHourTrading":{"tag":"盘前","latestPrice":2.3799,"preClose":2.34,"latestTime":"09:16 EDT","volume":289,"amount":658.9152315,"timestamp":1792156603669,"change":0.0399,"changeRate":0.017051,"amplitude":0.060556},"postHourTrading":{"tag":"盘后","latestPrice":2.22,"preClose":2.17,"latestTime":"19:57 EDT","volume":21020,"amount":46611.651,"timestamp":1792195076420,"change":0.05,"changeRate":0.023041,"amplitude":0.036866},"volumeRatio":1.4802996598928275,"impliedVol":1.6853,"impliedVolPercentile":0.6534},"requestUrl":"/m/hq/s/CATX","defaultTab":"news","newsList":[{"id":"1186435942","title":"Perspective Therapeutics携手默沙东，共启[212Pb]PSV359与Keytruda®联合治疗FAP-α阳性实体瘤的临床合作新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1186435942","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186435942?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:17","pubTimestamp":1789381035,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics今日宣布，已与全球制药巨头默沙东达成一项临床合作与供应协议，旨在深入评估其创新疗法[212Pb]PSV359与默沙东明星免疫检查点抑制剂Keytruda联合应用，针对FAP-α阳性实体瘤的治疗潜力。Perspective Therapeutics独具匠心地运用铅-212放射性同位素标记技术，开发出[212Pb]PSV359，力求实现对肿瘤微环境的精准打击。随着合作协议的尘埃落定，Perspective Therapeutics的研发管线价值有望获得重估，其在精准肿瘤学领域的战略地位亦将得到进一步巩固。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CATX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167834096","title":"Perspective Therapeutics第二季度每股亏损0.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167834096","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167834096?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:35","pubTimestamp":1786394132,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics公布第二季度净亏损达2678.6万美元。这一亏损数据，折合每股亏损0.22美元，反映出公司在当前季度面临的财务挑战。公司第二季度业绩报告显示，其净收入为负值，具体数字为-2678.6万美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CATX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121051750","title":"Perspective Therapeutics宣布Vmt-α-net数据获选在2026年ESMO大会上作口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1121051750","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121051750?lang=zh_cn&edition=full","pubTime":"2026-07-18 00:23","pubTimestamp":1784305392,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics宣布，其Vmt-α-net研究数据已被2026年欧洲肿瘤内科学会大会接收，并将以口头报告形式进行展示。这一进展标志着该公司的相关研究获得了国际权威学术会议的认可，有望提升其在肿瘤治疗领域的行业关注度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141357486","title":"Perspective Therapeutics拓展治疗领域；首位脑膜瘤患者接受[212PB]Vmt-Α-Net治疗，开启1/2a期研究新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1141357486","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141357486?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:31","pubTimestamp":1780482688,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics宣布拓展其核心治疗领域。公司在一项1/2a期临床试验的脑膜瘤患者队列中，已为第一位患者施用了新型放射性药物[212PB]Vmt-Α-Net。这标志着公司在探索靶向放射疗法用于治疗脑膜瘤方面迈出了关键一步，也体现了其将研发管线扩展到更广泛肿瘤类型的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119403546","title":"Perspective Therapeutics在2026年AACR年会上公布[212PB]VMT-α-NET正在进行的1/2a期临床试验最新中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1119403546","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119403546?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:02","pubTimestamp":1776679331,"startTime":"0","endTime":"0","summary":"生物制药企业Perspective Therapeutics于2026年美国癌症研究协会年会期间，公布了其核心靶向放射疗法[212PB]VMT-α-NET的1/2a期临床试验最新中期分析结果。该研究旨在评估这种创新疗法对神经内分泌肿瘤患者的治疗效果与安全性。最新数据显示，[212PB]VMT-α-NET在特定患者群体中展现出令人鼓舞的抗肿瘤活性，且整体耐受性良好。公司表示将持续推进该疗法的临床研究进程，并计划根据试验进展与监管机构沟通后续开发策略。此次数据更新标志着Perspective Therapeutics在精准放射药物领域取得的关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CATX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517916238","title":"Perspective Therapeutics, Inc.盘中异动 快速拉升5.14%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517916238?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:37","pubTimestamp":1741275473,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时37分，Perspective Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.96%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、古特拉、Volitionrx Limited涨幅较大，古特拉、Reshape Lifesciences, Inc.、908 Devices Inc.较为活跃，换手率分别为185.36%、9.16%、3.67%，振幅较大的相关个股有古特拉、飞天兆业、Sintx Technologies, Inc.，振幅分别为27.36%、21.21%、15.17%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306233753989ec1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306233753989ec1da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CATX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910060","title":"Perspective Therapeutics, Inc.盘中异动 早盘股价大涨5.92%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910060?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:35","pubTimestamp":1741185325,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时35分，Perspective Therapeutics, Inc.股票出现异动，股价急速上涨5.92%。截至发稿，该股报2.49美元/股，成交量8211股，换手率0.01%，振幅3.37%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223525abe9b20b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223525abe9b20b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516608237","title":"Perspective Therapeutics, Inc.盘中异动 大幅下跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516608237?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:59","pubTimestamp":1741100349,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时59分，Perspective Therapeutics, Inc.股票出现异动，股价大幅跳水5.28%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.60%。其相关个股中，908 Devices Inc.、Nexalin Technology Inc C/Wts 、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，908 Devices Inc.、Reshape Lifesciences, Inc.、Venus Concept Inc.较为活跃，换手率分别为107.40%、8.43%、8.38%，振幅较大的相关个股有908 Devices Inc.、Venus Concept Inc.、Senseonics Holdings, Inc.，振幅分别为35.35%、23.97%、16.09%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422591096394cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422591096394cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CATX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516632001","title":"Perspective Therapeutics, Inc.盘中异动 早盘快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516632001?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:59","pubTimestamp":1741013967,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时59分，Perspective Therapeutics, Inc.股票出现异动，股价快速下挫5.04%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为0.85%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、飞天兆业、古特拉涨幅较大，Tivic Health Systems, Inc.、Reshape Lifesciences, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为6.46%、4.85%、3.59%，振幅较大的相关个股有Venus Concept Inc.、Envoy Medical, Inc.、Pulmonx Corporation，振幅分别为15.78%、14.60%、14.50%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225927989a176a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225927989a176a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CATX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516374965","title":"Perspective Therapeutics, Inc.盘中异动 大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516374965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516374965?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:51","pubTimestamp":1740761490,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时51分，Perspective Therapeutics, Inc.股票出现波动，股价大幅上涨5.36%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.54%。其相关个股中，Ainos Inc C/Wts 29/07/2027 、Lensar, Inc.、Biosig Technologies, Inc.涨幅较大，Rapid Micro Biosystems, Inc.、Reshape Lifesciences, Inc.、Dih Holding Us, Inc.较为活跃，换手率分别为18.17%、9.25%、4.68%，振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Envveno Medical Corporation，振幅分别为151.66%、30.55%、26.63%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010051319896998b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010051319896998b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513208657","title":"Perspective Therapeutics, Inc.盘中异动 早盘大幅下跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513208657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513208657?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:35","pubTimestamp":1740407727,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时35分，Perspective Therapeutics, Inc.股票出现异动，股价急速跳水5.80%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为0.02%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、飞天兆业、拜尔德医疗涨幅较大，Vivos Therapeutics, Inc.、Reshape Lifesciences, Inc.、Sintx Technologies, Inc.较为活跃，换手率分别为8.81%、6.24%、5.48%，振幅较大的相关个股有Lucid Diagnostics Inc.、飞天兆业、沃氪医疗，振幅分别为20.55%、10.66%、9.77%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242235279890f686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242235279890f686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CATX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510060713","title":"Perspective Therapeutics, Inc.盘中异动 急速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510060713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510060713?lang=zh_cn&edition=full","pubTime":"2025-02-12 23:24","pubTimestamp":1739373851,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日23时24分，Perspective Therapeutics, Inc.股票出现波动，股价急速下挫5.07%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为1.05%。其相关个股中，Tivic Health Systems, Inc.、Intelligent Bio Solutions Inc.、Electromed, Inc.涨幅较大，Tivic Health Systems, Inc.、Intelligent Bio Solutions Inc.、Lifeward Ltd.较为活跃，换手率分别为1998.12%、6.26%、3.73%，振幅较大的相关个股有Tivic Health Systems, Inc.、Intelligent Bio Solutions Inc.、Dih Holding Us, Inc.，振幅分别为120.51%、19.23%、17.30%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021223241196207add&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021223241196207add&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CATX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509729670","title":"Perspective Therapeutics, Inc.盘中异动 临近午盘股价大跌5.28%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509729670?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:49","pubTimestamp":1738946986,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时49分，Perspective Therapeutics, Inc.股票出现异动，股价快速跳水5.28%。截至发稿，该股报3.23美元/股，成交量17.2498万股，换手率0.26%，振幅8.80%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.35%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004947a23d419f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004947a23d419f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CATX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509785008","title":"Perspective Therapeutics, Inc.盘中异动 股价大跌5.08%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509785008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509785008?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:08","pubTimestamp":1738872537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时08分，Perspective Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.71%。其相关个股中，Trisalus Life Sciences Inc C/Wts 10/08/28 、Nexalin Technology Inc C/Wts 、Nevro Corp.涨幅较大，Nanovibronix, Inc.、Nevro Corp.、Sensus Healthcare, Inc.较为活跃，换手率分别为28.76%、27.95%、15.75%，振幅较大的相关个股有Nanovibronix, Inc.、Tenon Medical Inc C/Wts 16/06/2028 、Hyperfine, Inc.，振幅分别为32.16%、30.81%、30.25%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207040857987cbe4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207040857987cbe4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509585258","title":"Perspective Therapeutics, Inc.盘中异动 下午盘股价大涨5.07%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509585258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509585258?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:24","pubTimestamp":1738783459,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时24分，Perspective Therapeutics, Inc.股票出现波动，股价快速拉升5.07%。截至发稿，该股报3.52美元/股，成交量37.1805万股，换手率0.55%，振幅5.52%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为1.36%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206032419abc3ba26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206032419abc3ba26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CATX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508468724","title":"Perspective Therapeutics, Inc.盘中异动 早盘急速拉升5.15%报3.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508468724?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:09","pubTimestamp":1738681799,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时09分，Perspective Therapeutics, Inc.股票出现异动，股价快速拉升5.15%。截至发稿，该股报3.47美元/股，成交量6.0459万股，换手率0.09%，振幅4.85%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.12%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231000a23930bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231000a23930bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CATX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149555","title":"Perspective Therapeutics, Inc.盘中异动 股价大跌5.21%报3.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149555?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Perspective Therapeutics, Inc.股票出现波动，股价快速下跌5.21%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.24%。其相关个股中，Trisalus Life Sciences, Inc.、Dih Holding Us, Inc.、古特拉涨幅较大，Reshape Lifesciences, Inc.、Nanovibronix, Inc.、Nuwellis, Inc.较为活跃，换手率分别为42.39%、5.58%、3.16%，振幅较大的相关个股有Beyond Air, Inc.、Electromed, Inc.、Pacific Biosciences Of California, Inc.，振幅分别为12.40%、8.69%、5.80%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322353198796faa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322353198796faa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CATX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508999107","title":"Perspective Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508999107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508999107?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:19","pubTimestamp":1738351148,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时19分，Perspective Therapeutics, Inc.股票出现波动，股价快速下跌5.12%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.20%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Biosig Technologies, Inc.、Sensus Healthcare, Inc.涨幅较大，Nanovibronix, Inc.、Nuwellis, Inc.、Helius Medical Technologies, Inc.较为活跃，换手率分别为51.22%、38.94%、14.32%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Tenon Medical Inc C/Wts 16/06/2028 、Nuwellis, Inc.，振幅分别为77.88%、50.27%、28.80%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103190898777feb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103190898777feb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CATX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507620685","title":"Perspective Therapeutics, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507620685?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:58","pubTimestamp":1738252686,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时58分，Perspective Therapeutics, Inc.股票出现波动，股价急速上涨5.26%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为0.49%。其相关个股中，Nanovibronix, Inc.、Nuwellis, Inc.、Butterfly Network, Inc.涨幅较大，Nanovibronix, Inc.、Nuwellis, Inc.、Allurion Technologies, Inc.较为活跃，换手率分别为950.97%、124.97%、3.49%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Nuwellis, Inc.、Envoy Medical Inc C/Wts 29/09/2028 ，振幅分别为79.81%、44.25%、35.65%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235806abbd5c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235806abbd5c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507432345","title":"Perspective Therapeutics, Inc.盘中异动 急速下挫5.09%报3.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507432345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507432345?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:37","pubTimestamp":1738082276,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时37分，Perspective Therapeutics, Inc.股票出现异动，股价大幅下跌5.09%。Perspective Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.24%。其相关个股中，Trinity Biotech Plc、Bone Biologics Corp C/Wts 13/10/2026 、Icad Inc.涨幅较大，Trinity Biotech Plc、Allurion Technologies, Inc.、Intelligent Bio Solutions Inc.较为活跃，换手率分别为363.00%、13.41%、6.17%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Trinity Biotech Plc、Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 ，振幅分别为69.00%、56.58%、39.47%。Perspective Therapeutics, Inc.公司简介：Perspective Therapeutics Inc 是一家医疗技术和放射性制药公司，致力于开创应用于全身癌症的各种治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129003756a23288a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129003756a23288a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.perspectivetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1842},{"period":"1month","weight":-0.1963},{"period":"3month","weight":-0.2742},{"period":"6month","weight":-0.4833},{"period":"1year","weight":-0.5432},{"period":"ytd","weight":-0.2109}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Perspective Therapeutics, Inc.于1983年根据明尼苏达州法律组建，后又在特拉华州重新注册成立。该公司是一家医疗技术和放射性药物公司，开创了针对全身癌症的先进治疗应用。该公司是Cesium-131近距离放射治疗种子的唯一生产商，并拥有一项专有技术，利用同位素铅-212通过专门的靶向肽向癌细胞提供强大的α辐射。该公司还在开发补充影像诊断技术，结合相同的靶向肽，提供个性化治疗和优化患者结果的机会。这种“治疗诊断”方法使人们能够看到特定的肿瘤，然后对其进行治疗，从而有可能提高疗效，并最大限度地减少与许多其他类型的癌症治疗相关的毒性。该公司的黑色素瘤（VMT01）和神经内分泌肿瘤（VMT-a-NET）项目正在几家领先的学术机构进入治疗转移性黑色素瘤和神经内分泌肿瘤的1/2a期成像和治疗试验。该公司还开发了一种专有的铅-212发生器，以确保为临床试验和商业运作提供同位素。","yearOnYearQuotes":[{"month":1,"riseRate":0.619048,"avgChangeRate":0.293818},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.037204},{"month":3,"riseRate":0.428571,"avgChangeRate":0.076583},{"month":4,"riseRate":0.571429,"avgChangeRate":0.095009},{"month":5,"riseRate":0.47619,"avgChangeRate":0.021737},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.030943},{"month":7,"riseRate":0.47619,"avgChangeRate":0.068297},{"month":8,"riseRate":0.380952,"avgChangeRate":0.048169},{"month":9,"riseRate":0.227273,"avgChangeRate":-0.096224},{"month":10,"riseRate":0.227273,"avgChangeRate":-0.077834},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.016464},{"month":12,"riseRate":0.380952,"avgChangeRate":-0.035368}],"exchange":"AMEX","name":"Perspective Therapeutics","nameEN":"Perspective Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Perspective Therapeutics(CATX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Perspective Therapeutics(CATX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Perspective Therapeutics,CATX,Perspective Therapeutics股票,Perspective Therapeutics股票老虎,Perspective Therapeutics股票老虎国际,Perspective Therapeutics行情,Perspective Therapeutics股票行情,Perspective Therapeutics股价,Perspective Therapeutics股市,Perspective Therapeutics股票价格,Perspective Therapeutics股票交易,Perspective Therapeutics股票购买,Perspective Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Perspective Therapeutics(CATX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Perspective Therapeutics(CATX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}